Fo-Ti
Fo-ti (He Shou Wu) is a traditional Chinese herb. Clinical evidence for specific outcomes is limited and liver safety warrants caution.
Overview
What is fo-ti?
Fo-Ti, He Shou Wu or Chinese Knotweed is the root of a climbing plant found predominantly in east Asia.
Dosage
Typical dosing information is unavailable.
Effect graph
Subscribe to view effect graphs
Interactive visualisations of ranked conditions and clinical benefit with purchase guidance.
Already a subscriber? Sign in
Effect heatmap
Subscribe to view effect heatmaps
See effect size, evidence strength, and trust at a glance for every condition.
Already a subscriber? Sign in
SupplementDEX Database
2 conditions for rated at least stars. All purchase bands. No minimum star filter.
Subscribe to access the SupplementDEX Database
Read this and 2,600+ other evidence reviews on our practitioner plan.
Already a subscriber? Sign in
Database Snapshot
Most fo-ti research is concentrated in a handful of conditions.
- Age-related cognitive decline accounts for 1 of 2 studies (50%).
- Dyslipidemia accounts for 1 of 2 studies (50%).
- Sparse coverage remains for Age-related cognitive decline, Dyslipidemia.
Safety
Fo-ti has been linked to liver damage in adults and children.
Special populations
Pregnancy & breastfeeding
AvoidAvoid use in people who are pregnant or lactating.
Frequently Asked Questions
References
Sources2 references
SupplementDEX uses only high-quality sources to determine supplement effectiveness.
1.SupplementDEX Database: Age-related cognitive decline — [Clinical study on a randomized, double-blind control of Shenwu gelatin capsule in treatment of mild cognitive impairment]2007
In a 3-month double-blind RCT of 166 patients with mild cognitive impairment, Shenwu gelatin capsule (containing ginseng and fleeceflower root) improved memory quotient similarly to aniracetam.
SupplementDEX Database · Dyslipidemia
1 reference2.SupplementDEX Database: Dyslipidemia — Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, double-blind, placebo-controlled clinical trial2014
In a 12-week double-blind RCT of 42 Chinese dyslipidemia patients, a multiherb formula including hawthorn reduced LDL cholesterol by 9% versus placebo; HbA1c also improved.